FSU: launches groundbreaking Institute for Pediatric Rare Diseases

Florida State University has launched the Institute for Pediatric Rare Diseases, an institute dedicated to advancing research and developing treatments for unusual childhood diseases, filling a critical gap in the health care industry.

The institute is made possible by a $1 million in funding from the Florida Legislature. Rep. Adam Anderson, R-Palm Harbor, whose son Andrew died from Tay-Sachs Disease, pushed for the funding, which was also supported by Gov. Ron DeSantis.

“Since our son Andrew’s diagnosis of Tay-Sachs Disease in 2016, my wife Brianne and I have made it our mission to do everything in our power to ensure other families don’t have to live that same nightmare that we did, but sadly many families do,” said Anderson, a Florida State alumnus. “There are currently 7,000 known rare diseases that impact over 350 million people globally and 30 million people nationwide. To put that into perspective, that’s nearly 10% of the population of our country and more than the entire population of Florida. So, while we call them rare, when looked at as a whole they are more frighteningly common than you think.”

The institute aims to harness the power of interdisciplinary collaboration, bringing together scientists, clinicians and educators to tackle the challenges of pediatric rare diseases. By leveraging the latest gene therapy and immune response research, the institute seeks to improve treatment outcomes and enhance the quality of life for the 15 million children across the United States affected by these conditions.

Anderson celebrated the launch of the new institute during FSU Day at the Capitol, surrounded by members of the FSU Board of Trustees, FSU President Richard McCullough, Institute Director Pradeep Bhide and other members of the FSU administration.

McCullough lauded Rep. Anderson for his work to secure funding in the state budget and see the institute come to fruition.

“We thank Rep. Anderson, the Florida Legislature and Gov. DeSantis for their vision and generous support of the FSU Institute for Pediatric Rare Diseases, the first institute of its kind in Florida,” McCullough said. “The institute will drive transformative progress of novel technologies to better diagnose and treat rare diseases including Tay-Sachs and glioblastoma in children by using artificial intelligence and DNA sequencing to develop promising new treatment options like gene therapy. FSU is committed to advancing cutting-edge science to help children and their families who are impacted by these devastating diseases.”

The institute will be housed in the FSU College of Medicine and led by Bhide, the Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience. The institute will focus on understanding the root causes of different pediatric rare diseases so that researchers can develop both diagnostic and treatment tools. The institute also hopes to launch a graduate program in genetic counseling and also develop a DNA sequencing facility.

“This is a unique opportunity for our faculty and students to join forces and work together to develop novel technologies for the diagnosis and treatment of pediatric rare diseases,” Bhide said. “We deeply appreciate the support of the State of Florida in funding this research for the benefit of all children and families — not just here in Florida, but everywhere. We have made tremendous progress in just a short time, and Florida can truly make a difference in the lives of our youngest citizens. We are grateful to Gov. DeSantis, Rep. Anderson and the entire Florida Legislature for their support of our work.”

 

 

Gideon Canice

Leave a Reply

Your email address will not be published. Required fields are marked *